Showing results (31-40 of 60) with videos related to
Sort By:
Pageof 6
Plos One|October 15, 2011
Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoidsYuval Avnir, Keren Turjeman, Deborah Tulchinsky, et al.Pharmaceutical Research|November 18, 2015
Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil(®)): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in TissuesYasmine Amitay, Hilary Shmeeda, Yogita Patil, et al.Langmuir : the ACS Journal of Surfaces and Colloids|February 27, 2007
Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibilityAvi Schroeder, Yuval Avnir, Sarah Weisman, et al.Onkologie|September 13, 2008
Primary amelanotic melanoma of the vaginaTal Grenader, Ruth Isacson, Constantin Reinus, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 14, 2025
Enhancing nanomedicine efficacy in KPC pancreatic tumors through ketotifen-mediated tumor microenvironment remodelingAntonia Charalambous, Fotios Mpekris, Chrysovalantis Voutouri, et al.Journal of Drug Targeting|May 18, 2016
Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancerHilary Shmeeda, Yasmine Amitay, Jenny Gorin, et al.International Journal of Radiation Oncology, Biology, Physics|March 18, 2023
Pegylated Liposomal Mitomycin C Lipidic Prodrug in Combination With External Beam Radiation Therapy in Patients With Advanced Cancer: A Phase 1B StudyEli Sapir, Raphael Pfeffer, Marc Wygoda, et al.Advanced Drug Delivery Reviews|August 11, 2020
Development of Promitil®, a lipidic prodrug of mitomycin c in PEGylated liposomes: From bench to bedsideAlberto Gabizon, Hilary Shmeeda, Esther Tahover, et al.Cancer Chemotherapy and Pharmacology|May 19, 2011
Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patientsNinh M La-Beck, Beth A Zamboni, Alberto Gabizon, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 14, 2010
Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cellsHilary Shmeeda, Yasmine Amitay, Jenny Gorin, et al.Pageof 6